Best Options Strategy for NTLA
Looking for the best options strategy for Intellia Therapeutics (NTLA)? There is no single answer — the right play depends on your outlook, your risk tolerance and current implied volatility. Below, our free engine shows the highest-scoring defined-risk strategy on the live NTLA option chain right now, and a simple map from your view on NTLA to the strategy that fits it. Model any of them in the calculator before you trade.
About NTLA
Intellia Therapeutics (NTLA) is a major company in CRISPR gene-editing therapies. Options traders on NTLA tend to watch clinical trial results, regulatory milestones and biotech sector sentiment, since these can drive large moves in the share price.
NTLA for options traders
Intellia Therapeutics (NTLA) is a clinical-stage CRISPR gene-editing company, and that identity shapes everything about its options. Because its value rests on a pipeline of experimental therapies rather than steady earnings, implied volatility tends to sit structurally high — the market is constantly pricing the possibility of a large gap in either direction. The catalysts that move it are binary and lumpy: readouts from clinical trials, regulatory milestones such as trial clearances or agency feedback, and the broader mood of the biotech sector, which can lift or crush every gene-editing name at once regardless of company-specific news. Options activity concentrates around these known event dates, so open interest and volume can spike near catalysts and thin out in quiet stretches, leaving wider bid-ask spreads on far-dated or deep out-of-the-money strikes.
Traders who think the market is over-paying for that fear often lean on premium-selling structures — iron condors, short strangles, or covered calls — to harvest the rich IV, especially in the calm windows between catalysts when theta works in their favor. The caveat specific to a name like this is gap risk: a single trial readout can send the stock through both wings of a condor overnight, so defined-risk spreads are usually preferred over naked strangles, and short-premium positions are frequently closed or trimmed before a scheduled event. Directional or event-driven traders instead buy long calls, debit spreads, or straddles to bet on a move or simply on volatility itself, accepting that elevated IV makes those options expensive and that a post-event volatility crush can erode value even when the stock moves their way.
Today's top-scoring strategy for NTLA
Our engine ranks defined-risk strategies on the live NTLA chain by probability of profit and risk/reward, then surfaces the best-scoring one. It is an educational illustration, not advice.
| Action | Qty | Type | Strike | Premium |
|---|---|---|---|---|
| Buy | 1× | CALL | $95 | $9.14 |
| Sell | 2× | CALL | $100 | $6.44 |
| Buy | 1× | CALL | $105 | $4.37 |
Simulation
Forward simulation of 6,000 lognormal price paths to expiration — not a historical backtest.
Strategy analysis
Greeks vs price
Price × volatility (today)
| −30% | −15% | IV | +15% | +30% | |
|---|---|---|---|---|---|
| $125 | −$49 | −$41 | −$37 | −$34 | −$33 |
| $120 | −$37 | −$30 | −$27 | −$26 | −$27 |
| $115 | −$19 | −$16 | −$17 | −$19 | −$22 |
| $110 | $2 | −$3 | −$8 | −$13 | −$17 |
| $105 | $20 | $8 | −$1 | −$9 | −$14 |
| $100 | $26 | $11 | $0 | −$8 | −$14 |
| $95 | $16 | $4 | −$4 | −$11 | −$17 |
| $90 | −$8 | −$11 | −$15 | −$19 | −$22 |
| $85 | −$33 | −$29 | −$28 | −$29 | −$30 |
| $80 | −$51 | −$45 | −$41 | −$39 | −$38 |
| $75 | −$60 | −$56 | −$52 | −$49 | −$47 |
Illustrative example at NTLA's latest available price, computed with the same engine as the tool. Live option fills and the real IV skew refresh during US market hours.
Implied volatility
NTLA typically trades with elevated implied volatility, so its options carry richer premiums. Implied volatility drives option prices, so it is worth checking the live chain before you trade.
NTLA insider trading activity (SEC Form 4)
Open-market insider transactions at NTLA over roughly the last six months, from SEC Form 4 filings. Open-market buys are the rarer, more telling signal — routine selling under pre-arranged plans is common, so read a net-selling figure with that in mind.
| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| LEONARD JOHN M | Sell | 2,785 | $36K | 2026-08-21 |
| LEONARD JOHN M | Sell | 19,890 | $251K | 2026-08-20 |
| Dulac Edward J III | Sell | 8,111 | $91K | 2026-07-22 |
| Dulac Edward J III | Sell | 4,677 | $84K | 2026-07-02 |
| Dube Michael P | Sell | 2,641 | $44K | 2026-07-01 |
Source: SEC Form 4 filings via Finnhub. Open-market purchases (P) and sales (S) only — grants, option exercises, gifts and tax withholding are excluded. Informational context, not investment advice.
Earnings & IV crush
NTLA's next earnings report is due around November 5, 2026. Options that expire after it price in a binary move, so their implied volatility is elevated and usually collapses right after the announcement — an "IV crush". If your expiration falls before this date, the trade sidesteps the event.
Key figures
- Market cap
- $1.8B
- Beta (vs market)
- 1.82
- 52-week range
- $7.95–$28.25
- Short interest
- 40.4% of float · 12.3 days to cover
With 40.4% of NTLA's float sold short, squeeze and gap risk are elevated — one reason its options can stay expensive.
How to choose an options strategy for NTLA
Start with your outlook on NTLA, then match it to a defined-risk structure. Here are the most common choices and when each makes sense:
Bullish
Buy a call for leverage with capped risk, or a bull call spread to lower the cost and breakeven when you have a target price.
Long Call → Bull Call Spread →Bearish
Buy a put to profit from a decline with defined risk, or a bear put spread to cheapen the trade when you expect a measured move down.
Long Put → Bear Put Spread →Neutral
Sell an iron condor to collect premium while NTLA stays between two strikes, or write a covered call against shares you already own.
Iron Condor → Covered Call →⧉ Embed this free calculator on your site →
How we pick the best strategy
For each ticker we pull the live option chain, build every supported strategy around the at-the-money strikes, and score them on probability of profit, risk/reward and capital efficiency — favouring defined-risk structures where the maximum loss is known up front. Methodology →
Open NTLA in the free calculator →
Frequently asked questions
What is the best options strategy for NTLA?
It depends on your outlook. Bullish traders often use a long call or bull call spread on NTLA; bearish traders a long put or bear put spread; neutral traders an iron condor or covered call. Our live scan above shows the current highest-scoring defined-risk play.
Are NTLA options liquid enough to trade?
Intellia Therapeutics (NTLA) is among the most actively-traded US options, which usually means tight bid/ask spreads and plenty of strikes and expirations — though you should always check the open interest and spread on the exact contract.
How much money do I need to trade NTLA options?
Buying a single NTLA call or put can cost as little as the premium (often one to a few hundred dollars), while income strategies like a cash-secured put need enough capital to buy 100 shares if assigned.
Is this financial advice?
No. Everything here is educational and uses delayed, third-party data. It is not a recommendation to trade NTLA or any security. Do your own research.
What does Intellia Therapeutics do?
Intellia Therapeutics (NTLA) operates in the Biotechnology industry. The "About Intellia Therapeutics" section above gives a fuller picture of what the company does and how it earns money.
Does Intellia Therapeutics pay a dividend?
We don't show a confirmed dividend yield for Intellia Therapeutics here, so treat it as uncertain: before writing calls, check its current dividend and ex-dividend date with your broker — an approaching ex-dividend date can trigger early assignment on in-the-money short calls.
When does Intellia Therapeutics next report earnings?
Intellia Therapeutics's next earnings are expected around November 5, 2026. Implied volatility usually climbs into the report and drops sharply afterwards (IV crush) — important for any options position held over the date.
Tickers related to NTLA
Comparing NTLA with similar names can help you choose the best options strategy:
Company information
- Headquarters
- 40 Erie Street, Suite 130, Cambridge, MA, 02139, United States
- Industry
- Biotechnology
- Employees
- 377
- CEO
- Dr. John M. Leonard M.D.
- Phone
- 857 285 6200
- Website
- www.intelliatx.com
Best Options Strategy by Ticker →
Educational use only. Quotes are delayed ~15 minutes and nothing here is financial advice. Options trading involves substantial risk of loss. Privacy · Terms.